Designed spiroketal protein Modulation

M. Scheepstra, S.A. Andrei, M Y. Unver, A.K.H. Hirsch, S. Leysen, C. Ottmann, L. Brunsveld (Corresponding author), L.-G. Milroy (Corresponding author)

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
88 Downloads (Pure)

Abstract

Spiroketals are structural motifs found in many biologically active natural products, which has stimulated considerable efforts toward their synthesis and interest in their use as drug lead compounds. Despite this, the use of spiroketals, and especially bisbenzanulated spiroketals, in a structure-based drug discovery setting has not been convincingly demonstrated. Herein, we report the rational design of a bisbenzannulated spiroketal that potently binds to the retinoid X receptor (RXR) thereby inducing partial co-activator recruitment. We solved the crystal structure of the spiroketal-hRXRα-TIF2 ternary complex, and identified a canonical allosteric mechanism as a possible explanation for the partial agonist behavior of our spiroketal. Our co-crystal structure, the first of a designed spiroketal-protein complex, suggests that spiroketals can be designed to selectively target other nuclear receptor subtypes.

Original languageEnglish
Pages (from-to)5480-5484
Number of pages5
JournalAngewandte Chemie - International Edition
Volume56
Issue number20
DOIs
Publication statusPublished - 8 May 2017

Keywords

  • drug design
  • drug discovery
  • natural products
  • spiro compounds
  • structure elucidation

Fingerprint Dive into the research topics of 'Designed spiroketal protein Modulation'. Together they form a unique fingerprint.

Cite this